Ulrich Dauer, a founder and former chief executive of 4SC AG, has been appointed chief strategy officer for Activaero GmbH, a private German company specialising in treatments for respiratory diseases. Dr Dauer will help Activaero, which has an asthma product approaching registration, through its next stage of development.
Dr Dauer received his PhD from the Institute of Organic Chemistry at the University of Würzburg.
Activaero announced the appointment on 11 November 2013.
Copyright 2013 Evernow Publishing Ltd